Cargando…
Catecholamines : bridging basic science with clinical medicine /
This volume in Advances in Pharmacology focuses on all aspects of catecholamine research, from very basic to medical. It is broad based and covers many areas within physiology and medicine.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego :
Academic Press,
�1998.
|
| Colección: | Advances in pharmacology ;
v. 42. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Catecholamines: Bridging Basic Science with Clinical Medicine; Copyright Page; Contents; Contributors; Preface; PART A: CATECHOLAMINE SYNTHESIS AND RELEASE; Overview; Section I: Regulation and Expression of Tyrosine Hydroxylase; Chapter 1. The Effect of Phosphorylation at Ser-40 on the Structure and Thermal Stability of Tyrosine Hydroxylase; Chapter 2. Factors Affecting Adrenal Medullary Catecholamine Biosynthesis and Release; Chapter 3. Regulation of Tyrosine Hydroxylase by Neuropeptides.
- Chapter 4. Regulation of Tyrosine Hydroxylase Gene Expression by Transsynaptic Mechanisms and Cell-Cell ContactChapter 5. A New Regulatory Protein of Catecholamine Synthesizing- Enzyme Expression; Chapter 6. Unique and Cell-Type-Specific Tyrosine Hydroxylase Gene Expression; Chapter 7. Triple Colocalization of Tyrosine Hydroxylase, Calretinin, and Calbindin D-28k in the Periventricular-Hypophyseal Dopaminergic Neuronal System; Chapter 8. Genetic Disorders Involving Recycling and Formation of Tetrahydrobiopterin; Chapter 9. Genetic Basis of Dominant Dystonia.
- Chapter 10. Mutations in the Tyrosine Hydroxylase Gene Cause Various Forms of L-Dopa-Responsive DystoniaChapter 11. Catecholamine Biosynthetic Enzyme Expression in Neurological and Psychiatric Disorders; Section II: Other Catecholamine-Synthesizing Enzymes; Chapter 12. Multiple Pathways in Regulation of Dopamine �-Hydroxylase; Chapter 13. Examining Adrenergic Roles in Development, Physiology, and Behavior through Targeted Disruption of the Mouse Dopamine �-Hydroxylase Gene; Chapter 14. Genetic Diseases of Hypotension.
- Chapter 15. Dopamine �-Hydroxylase Deficiency Associated with Mutations in a Copper Transporter GeneChapter 16. Glucocorticoid-Phenylethanolamine-N-methyltransferase Interactions in Humans; Chapter 17. Determinants of Phenylethanolamine-N- methyltransferase Expression; Chapter 18. Neural Control of Phenylethanolamine-N- methyltransferase via Cholinergic Activation of Egr- I; Chapter 19. Synexin (Annexin VII) Hypothesis for Ca2+/GTP-Regulated Exocytosis; Chapter 20. Monoamine Transmitter Release from Small Synaptic and Large Dense-Core Vesicles.
- Chapter 21. Calcium Channels for Exocytosis in Chromaffin CellsChapter 22. Characteristics of Transmitter Secretion from Individual Sympathetic Varicosities; Chapter 23. Neurotransmitter Release at Individual Sympathetic Varicosities, Boutons; Chapter 24. Appropriate Target Cells Are Required for Maturation of Neurotransmitter Release Function of Sympathetic Neurons in Culture; Chapter 25. Effects of Neuropeptide Y at Sympathetic Neuroeffector Junctions; Chapter 26. Strategies for Receptor Control of Neurotransmitter Release.